Company profile

Olive

Olive has raised $902 million across multiple rounds, including a landmark $400M Series H in July 2021 at a $4B valuation. Earlier, the company secured $226 million in Series G funding (2020) at a $1.5 billion valuation and $106 million in Series F, bringing its total capital above $700 million within one year. Backed by Tiger Global, Dragoneer, Vista Equity, and General Catalyst, Olive rapidly scaled its AI automation platform for healthcare administration. Founded in 2012, the company achieved unicorn status within 8 years and 11 months, becoming one of the fastest-scaling AI startups in healthcare IT.

Back to profiles

Quick facts

Total funding: $902 million
Valuation: $4B
Founded: 2012

Notable investors

Tiger Global
Dragoneer
Vista Equity
General Catalyst

Reach buyers like Olive on TexAu

TexAu helps go-to-market teams find, enrich, and reach companies that match this profile. Pick the path that fits how you work.

Find companies like Olive
Build a list by industry, headcount, funding stage, or technographics. Get verified emails and direct dials.
Start a free workspace
Enrich your CRM with company data
Push funding, headcount, hiring signals, and tech stack into HubSpot, Salesforce, or a spreadsheet. Waterfall enrichment.
See how the waterfall works
Run it on a schedule
Refresh the list weekly, score new accounts as they land, and push the ones that fit to Smartlead, Instantly, Lemlist, HeyReach, or Apollo Sequences.
See how schedulers work

Reach buyers like Olive.

The 14-day trial ships every feature, no card required.

Start free →